← Leaderboards
Elizabeth A Proctor
Univ Of North Carolina Chapel Hill
$1,329,360
Attributed
$3,587,615
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $777.9K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,587,615 · 3
By mechanism
R01$3,058,861 · 1
R21$438,028 · 1
F31$90,726 · 1
Top collaborators
- Patrick James Drew4 shared
- Bruce J Gluckman4 shared
- Nanyin Zhang1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Dea Garic$606,819
- Ilona Jaspers$20,767,326
- Ned Porter$13,848,998
- Rachel Redler$253,196
- Roza Vlasova$155,500
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAffectMolecularEventNeurotoxicPathway InteractionsVariantNeuroinflammationBlood VesselsPathologicAgingAnimalsInflammatoryBrainMachine LearningCytokineGenesBrain CellCerebrovascular CirculationBlood FlowAwakeInflammationBehavioralImmune
Grant awards (8)
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain$739,802
R01 · FY2025 · AG · contact PI
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain$777,912
R01 · FY2024 · AG · contact PI
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain$764,728
R01 · FY2023 · AG · contact PI
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain$776,419
R01 · FY2022 · AG · contact PI
Coupling and spread of molecular and functional pathology of Alzheimer's disease$438,028
R21 · FY2021 · AG · contact PI
Identification of drug leads targeting SOD1 dissociation for the treatment of ALS$30,526
F31 · FY2013 · AG · contact PI
Identification of drug leads targeting SOD1 dissociation for the treatment of ALS$30,526
F31 · FY2012 · AG · contact PI
Identification of drug leads targeting SOD1 dissociation for the treatment of ALS$29,674
F31 · FY2010 · AG · contact PI